Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population

Abstract

Nude mice are a superior platform than NSG mice for generating PDXs from gastric cancer patients. Lenvatinib showed promising antitumor activity in PDXs established from a diverse Western patient population and warrants further investigation in gastric cancer.